| Year |
Citation |
Score |
| 2023 |
Manisundaram N, DiBrito SR, Hu CY, Kim Y, Wick E, Palis B, Peacock O, Chang GJ. Reporting of Circumferential Resection Margin in Rectal Cancer Surgery. Jama Surgery. PMID 37728906 DOI: 10.1001/jamasurg.2023.4221 |
0.388 |
|
| 2022 |
Aiken T, Hu CY, Uppal A, Francescatti AB, Fournier KF, Chang GJ, Zafar SN. Peritoneal recurrence after resection for Stage I-III colorectal cancer: A population analysis. Journal of Surgical Oncology. PMID 36519668 DOI: 10.1002/jso.27175 |
0.399 |
|
| 2022 |
Snyder RA, Hu CY, DiBrito SR, Chang GJ. Association of Medicaid Expansion with Racial Disparities in Cancer Stage at Presentation. Cancer. PMID 35818763 DOI: 10.1002/cncr.34347 |
0.328 |
|
| 2020 |
Healy MA, Peacock O, Hu CY, Bednarski BK, Tillman MM, Messick C, Kaur H, Chang GJ. High Rate of Positive Circumferential Resection Margin in Colon Cancer: A National Appraisal and Call for Action. Annals of Surgery. PMID 33630474 DOI: 10.1097/SLA.0000000000004682 |
0.334 |
|
| 2020 |
Snyder RA, Hu CY, Zafar SN, Francescatti A, Chang GJ. Racial Disparities in Recurrence and Overall Survival in Patients with Locoregional Colorectal Cancer. Journal of the National Cancer Institute. PMID 33231683 DOI: 10.1093/jnci/djaa182 |
0.43 |
|
| 2020 |
Malakorn S, Ouchi A, Hu CY, Sandhu L, Dasari A, You YN, Kopetz ES, Ellis LM, Chang GJ. Tumor Sidedness, Recurrence, and Survival After Curative Resection of Localized Colon Cancer. Clinical Colorectal Cancer. PMID 33004292 DOI: 10.1016/J.Clcc.2020.08.007 |
0.502 |
|
| 2020 |
Patel SH, Hu CY, Massarweh NN, You YN, McCabe R, Dietz D, Facktor MA, Chang GJ. Circumferential Resection Margin as a Hospital Quality Assessment Tool for Rectal Cancer Surgery. Journal of the American College of Surgeons. PMID 32142927 DOI: 10.1016/j.jamcollsurg.2020.02.033 |
0.303 |
|
| 2020 |
Zafar SN, Hu CY, Snyder RA, Cuddy A, You YN, Lowenstein LM, Volk RJ, Chang GJ. Predicting Risk of Recurrence After Colorectal Cancer Surgery in the United States: An Analysis of a Special Commission on Cancer National Study. Annals of Surgical Oncology. PMID 32080809 DOI: 10.1245/S10434-020-08238-7 |
0.457 |
|
| 2020 |
Peacock O, Limvorapitak T, Hu C, Bednarski BK, Taggart M, Dasari A, Kopetz S, Holliday EB, Das P, You YN, Chang GJ. Improving the AJCC/TNM staging classification for colorectal cancer: The prognostic impact of tumor deposits. Journal of Clinical Oncology. 38: 4012-4012. DOI: 10.1200/Jco.2020.38.15_Suppl.4012 |
0.477 |
|
| 2019 |
Zafar SN, Snyder R, Hu C, Francescatti A, Van Loon K, Chang GJ. National Comparative Analysis of Survival after Recurrence of Colon and Rectal Cancer Journal of the American College of Surgeons. 229: e201. DOI: 10.1016/J.Jamcollsurg.2019.08.1288 |
0.494 |
|
| 2018 |
Wong ML, McMurry TL, Schumacher JR, Hu CY, Stukenborg GJ, Francescatti AB, Greenberg CC, Chang GJ, McKellar DP, Walter LC, Kozower BD. Comorbidity Assessment in the National Cancer Database for Patients With Surgically Resected Breast, Colorectal, or Lung Cancer (AFT-01, -02, -03). Journal of Oncology Practice. JOP1800175. PMID 30207852 DOI: 10.1200/Jop.18.00175 |
0.353 |
|
| 2018 |
Snyder RA, Hu CY, Cuddy A, Francescatti AB, Schumacher JR, Van Loon K, You YN, Kozower BD, Greenberg CC, Schrag D, Venook A, McKellar D, Winchester DP, Chang GJ. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer. Jama. 319: 2104-2115. PMID 29800181 DOI: 10.1001/Jama.2018.5816 |
0.379 |
|
| 2017 |
Adesoye T, Hu C, Cuddy A, Francescatti AB, Schumacher JR, You YN, Loon KV, Schrag D, McKellar DP, Winchester DP, Chang GJ. Impact of adjuvant chemotherapy on recurrence risk in stage II colon cancer. Journal of Clinical Oncology. 35: 533-533. DOI: 10.1200/Jco.2017.35.4_Suppl.533 |
0.525 |
|
| 2017 |
Snyder RA, Hu C, Cuddy A, Francescatti AB, Schumacher JR, You YN, Schrag D, McKellar D, Winchester DP, Kozower BD, Greenberg CC, Chang GJ. Impact of intensity of post-treatment surveillance on survival in colorectal cancer. Journal of Clinical Oncology. 35: 10016-10016. DOI: 10.1200/Jco.2017.35.15_Suppl.10016 |
0.4 |
|
| 2016 |
Van Loon K, You YN, Hu CY, Francescatti AB, Greenberg CC, Venook AP, Schrag D, Chang GJ. How clinicians make decisions regarding surveillance and treatment of colorectal cancer (CRC) patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 263. PMID 28151232 DOI: 10.1200/Jco.2016.34.3_Suppl.263 |
0.439 |
|
| 2016 |
Alawadi Z, Phatak UR, Hu CY, Bailey CE, You YN, Kao LS, Massarweh NN, Feig BW, Rodriguez-Bigas MA, Skibber JM, Chang GJ. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer. PMID 27479827 DOI: 10.1002/cncr.30230 |
0.45 |
|
| 2016 |
Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Das P, Eng C, Kopetz S, Wolff RA, Crane CH, Krishnan S, Minsky B, Hu CY, Nguyen S, Chang GJ. Oncologic and Functional Hazards of Obesity Among Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiation Therapy. American Journal of Clinical Oncology. PMID 27028350 DOI: 10.1097/COC.0000000000000150 |
0.339 |
|
| 2016 |
Van Loon K, Hu C, Cuddy A, Bekaii-Saab TS, Benson AB, Hall MJ, Lai LL, Nurkin SJ, Skibber JM, Weiser MR, Schrag D, Chang GJ. How are colorectal cancer (CRC) patients treated following cancer recurrence during follow-up? Journal of Clinical Oncology. 34: 645-645. DOI: 10.1200/Jco.2016.34.4_Suppl.645 |
0.45 |
|
| 2016 |
Snyder RA, Hu C, Cuddy A, Francescatti AB, Schumacher JR, You YN, McKellar D, Winchester DP, Chang GJ. Detection and treatment of colorectal cancer (CRC) recurrence during routine surveillance: A nationwide cohort study. Journal of Clinical Oncology. 34. DOI: 10.1200/Jco.2016.34.15_Suppl.E18137 |
0.427 |
|
| 2016 |
Cuddy A, Hu C, Snyder RA, Francescatti AB, Schumacher JR, You YN, McKellar D, Winchester DP, Chang GJ. Variation in colorectal cancer (CRC) post-treatment surveillance intensity (SI) and detection of recurrence. Journal of Clinical Oncology. 34: 6579-6579. DOI: 10.1200/Jco.2016.34.15_Suppl.6579 |
0.405 |
|
| 2015 |
Hu CY, Bailey CE, Chang GJ. Less Surgery, Improved Survival From Stage IV Colorectal Cancer?-Reply. Jama Surgery. PMID 26107989 DOI: 10.1001/jamasurg.2015.0683 |
0.376 |
|
| 2015 |
Kneuertz PJ, Chang GJ, Hu CY, Rodriguez-Bigas MA, Eng C, Vilar E, Skibber JM, Feig BW, Cormier JN, You YN. Overtreatment of young adults with colon cancer: more intense treatments with unmatched survival gains. Jama Surgery. 150: 402-9. PMID 25806815 DOI: 10.1001/jamasurg.2014.3572 |
0.354 |
|
| 2015 |
Zheng Z, Jemal A, Lin CC, Hu CY, Chang GJ. Comparative effectiveness of laparoscopy vs open colectomy among nonmetastatic colon cancer patients: an analysis using the National Cancer Data Base. Journal of the National Cancer Institute. 107. PMID 25663688 DOI: 10.1093/jnci/dju491 |
0.32 |
|
| 2015 |
Hu CY, Bailey CE, You YN, Skibber JM, Rodriguez-Bigas MA, Feig BW, Chang GJ. Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival. Jama Surgery. 150: 245-51. PMID 25588105 DOI: 10.1001/jamasurg.2014.2253 |
0.411 |
|
| 2015 |
Bailey CE, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. Jama Surgery. 150: 17-22. PMID 25372703 DOI: 10.1001/jamasurg.2014.1756 |
0.306 |
|
| 2015 |
Alawadi Z, Phatak U, Hu C, Bailey CE, Kao L, You YN, Chang GJ. Comparative effectiveness of primary tumor resection in metastatic colon cancer: An instrumental variable analysis. Journal of Clinical Oncology. 33: 674-674. DOI: 10.1200/Jco.2015.33.3_Suppl.674 |
0.496 |
|
| 2015 |
Bailey CE, Hu C, You YN, Cuddy A, Liles JS, Chang GJ. Definitive surgical salvage treatment for recurrent colon cancer. Journal of Clinical Oncology. 33: e14704-e14704. DOI: 10.1200/Jco.2015.33.15_Suppl.E14704 |
0.493 |
|
| 2015 |
Xing Y, Mosalpuria K, Hu C, Bhatt VR, Ganti AK. Conditional survival estimates for small cell lung cancer receiving prophylactic cranial irradiation in the U.S. (1988-1997). Journal of Clinical Oncology. 33: 7577-7577. DOI: 10.1200/Jco.2015.33.15_Suppl.7577 |
0.485 |
|
| 2015 |
Mosalpuria K, Xing Y, Hu C, Bhatt VR, Ganti AK. Conditional survival estimates for lung cancer histologic subtypes in the U.S. (2004-2008). Journal of Clinical Oncology. 33: 7550-7550. DOI: 10.1200/Jco.2015.33.15_Suppl.7550 |
0.474 |
|
| 2014 |
Hu CY, Cuddy A, You YN, Chang GJ. Surveillance imaging following colon cancer resection: Universal or risk-based? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 307. PMID 28141429 DOI: 10.1200/Jco.2014.32.30_Suppl.307 |
0.474 |
|
| 2014 |
Massarweh NN, Hu CY, You YN, Bednarski BK, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Cormier JN, Feig BW, Chang GJ. Risk-adjusted pathologic margin positivity rate as a quality indicator in rectal cancer surgery. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: 2967-74. PMID 25092785 DOI: 10.1200/JCO.2014.55.5334 |
0.37 |
|
| 2014 |
Maru DM, Agarwal AA, Hu CY, Chang GJ. Reply to Can quantified pathologic response assessed as residual tumor burden be a promising staging system for patients with rectal cancer treated with chemoradiation followed by surgery? Cancer. 120: 1282. PMID 24474599 DOI: 10.1002/cncr.28559 |
0.357 |
|
| 2014 |
Haynes AB, You YN, Hu CY, Eng C, Kopetz ES, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007. Cancer. 120: 1162-70. PMID 24474245 DOI: 10.1002/cncr.28545 |
0.428 |
|
| 2014 |
Bailey CE, Hu C, You YN, Chang GJ. Increasing disparities in age-related incidence of colon and rectal cancer in the United States, 1975-2010. Journal of Clinical Oncology. 32: 392-392. DOI: 10.1200/Jco.2014.32.3_Suppl.392 |
0.46 |
|
| 2014 |
Xing Y, Hu C, Lee M, Seery VJ, Kim CC, Tawa NE, Frankenthaler RA, McDermott DF, Buchbinder EI. Association between mitotic rate and lymph node metastasis in thin melanoma in the general population.. Journal of Clinical Oncology. 32: e20039-e20039. DOI: 10.1200/Jco.2014.32.15_Suppl.E20039 |
0.341 |
|
| 2014 |
Bailey CE, Hu C, You YN, Bednarski B, Rodriguez-Bigas MA, Skibber JM, Cantor SB, Chang GJ. Disparities in age-related incidence of colon and rectal cancer in the United States, 1975-2010. Journal of Clinical Oncology. 32: 6579-6579. DOI: 10.1200/Jco.2014.32.15_Suppl.6579 |
0.461 |
|
| 2014 |
Bailey C, Cao HST, Hu C, Chang GJ, Feig BW, Rodriguez-Bigas M, Nguyen S, Skibber JM, You YN. 367 Persistent Functional Deficits and Symptoms Among Long-Term Survivors of Colorectal Cancer Treated With Surgery and Multimodality Therapy: Differences by Age at Initial Diagnosis Gastroenterology. 146: S-1012. DOI: 10.1016/S0016-5085(14)63680-5 |
0.348 |
|
| 2014 |
Livengood M, You YN, Hu C, Bailey CE, Tran Cao HS, Nguyen ST, Westney OL. MP80-17 URINARY SYMPTOMS PERSIST IN YOUNG COLORECTAL SURVIVORS WHO UNDERWENT PELVIC SURGERY AT LONG-TERM FOLLOW-UP Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.2540 |
0.357 |
|
| 2014 |
Phatak U, Hu C, You Y, Feig B, Skibber J, Rodriguez-Bigas M, Cormier J, Kao L, Chang G. Primary Tumor Resection in Metastatic Colon Cancer: A Propensity Score Analysis of the National Cancer Data Base Journal of Surgical Research. 186: 641. DOI: 10.1016/J.Jss.2013.11.664 |
0.464 |
|
| 2013 |
Agarwal A, Chang GJ, Hu CY, Taggart M, Rashid A, Park IJ, You YN, Das P, Krishnan S, Crane CH, Rodriguez-Bigas M, Skibber J, Ellis L, Eng C, Kopetz S, et al. Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with rectal cancer who undergo resection after neoadjuvant chemoradiotherapy. Cancer. 119: 4231-41. PMID 24089344 DOI: 10.1002/cncr.28331 |
0.383 |
|
| 2013 |
Russell MC, You YN, Hu CY, Cormier JN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Nelson H, Chang GJ. A novel risk-adjusted nomogram for rectal cancer surgery outcomes. Jama Surgery. 148: 769-77. PMID 23803722 DOI: 10.1001/jamasurg.2013.2136 |
0.413 |
|
| 2013 |
Bowles TL, Hu CY, You NY, Skibber JM, Rodriguez-Bigas MA, Chang GJ. An individualized conditional survival calculator for patients with rectal cancer. Diseases of the Colon and Rectum. 56: 551-9. PMID 23575393 DOI: 10.1097/DCR.0b013e31827bd287 |
0.383 |
|
| 2013 |
Yi M, Xu J, Liu P, Chang GJ, Du XL, Hu CY, Song Y, He J, Ren Y, Wei Y, Yang J, Hunt KK, Li X. Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer. British Journal of Cancer. 108: 1508-14. PMID 23470470 DOI: 10.1038/Bjc.2013.97 |
0.54 |
|
| 2013 |
Hu CY, Xing Y, Cormier JN, Chang GJ. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival. Cancer. 119: 1900-7. PMID 23408226 DOI: 10.1002/cncr.27968 |
0.331 |
|
| 2013 |
Park IJ, You YN, Skibber JM, Rodriguez-Bigas MA, Feig B, Nguyen S, Hu CY, Chang GJ. Comparative analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy. Diseases of the Colon and Rectum. 56: 135-41. PMID 23303140 DOI: 10.1097/DCR.0b013e318278ff8a |
0.325 |
|
| 2013 |
Boland GM, Chang GJ, Haynes AB, Chiang YJ, Chagpar R, Xing Y, Hu CY, Feig BW, You YN, Cormier JN. Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer. Cancer. 119: 1593-601. PMID 23280510 DOI: 10.1002/cncr.27935 |
0.41 |
|
| 2013 |
Overman MJ, Fournier K, Hu CY, Eng C, Taggart M, Royal R, Mansfield P, Chang GJ. Improving the AJCC/TNM staging for adenocarcinomas of the appendix: the prognostic impact of histological grade. Annals of Surgery. 257: 1072-8. PMID 23001080 DOI: 10.1200/Jco.2012.30.4_Suppl.402 |
0.401 |
|
| 2013 |
Bailey CE, Hu C, You YN, Rodriguez-Bigas MA, Kaur H, Ernst R, Skibber JM, Chang GJ. Population-based trends in positron emission tomography (PET) utilization after resection for colon cancer. Journal of Clinical Oncology. 31: 365-365. DOI: 10.1200/Jco.2013.31.4_Suppl.365 |
0.412 |
|
| 2012 |
Overman MJ, Fournier KF, Hu CY, Wolff RA, Eng C, Taggart MW, Royal RE, Mansfield PF, Chang GJ. Improving the AJCC/TNM staging for adenocarcinomas of the appendix: The prognostic impact of histologic grade. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 402. PMID 27983332 DOI: 10.1200/jco.2012.30.4_suppl.402 |
0.307 |
|
| 2012 |
Chang GJ, Hu CY, You YN, Eng C, Rodriguez-Bigas MA, Skibber JM. What determines adjuvant chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 546. PMID 27983265 DOI: 10.1200/Jco.2012.30.4_Suppl.546 |
0.461 |
|
| 2012 |
Boland GM, Chiang Y, Chagpar R, Xing Y, Hu CY, Feig BW, Chang GJ, You YN, Cormier JN. Association of NCCN guideline adherence with improved survival in high-risk stage II and stage III colon cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 543. PMID 27983253 DOI: 10.1200/Jco.2012.30.4_Suppl.543 |
0.479 |
|
| 2012 |
Abbott DE, Cantor SB, Hu CY, Aloia TA, You YN, Nguyen S, Chang GJ. Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases. Journal of the American College of Surgeons. 215: 262-70. PMID 22560316 DOI: 10.1016/j.jamcollsurg.2012.03.021 |
0.334 |
|
| 2012 |
Chang GJ, You YN, Park IJ, Kaur H, Hu CY, Rodriguez-Bigas MA, Skibber JM, Ernst RD. Pretreatment high-resolution rectal MRI and treatment response to neoadjuvant chemoradiation. Diseases of the Colon and Rectum. 55: 371-7. PMID 22426259 DOI: 10.1097/Dcr.0B013E31824678E3 |
0.38 |
|
| 2012 |
Katz MH, Hu CY, Fleming JB, Pisters PW, Lee JE, Chang GJ. Clinical calculator of conditional survival estimates for resected and unresected survivors of pancreatic cancer. Archives of Surgery (Chicago, Ill. : 1960). 147: 513-9. PMID 22351874 DOI: 10.1001/archsurg.2011.2281 |
0.308 |
|
| 2012 |
Hu CY, Chan W, Delclos GP, Du XL. Adjuvant chemotherapy and risk of gastrointestinal, hematologic, and cardiac toxicities in elderly patients with stage III colon cancer. American Journal of Clinical Oncology. 35: 228-36. PMID 21383605 DOI: 10.1097/Coc.0B013E318210F812 |
0.593 |
|
| 2011 |
Chang GJ, Park IJ, You YN, Hu C, Hamilton SR, Eng C, Feig BW, Das P, Krishnan S, Crane CH, Nguyen ST, Rodriguez-Bigas MA, Skibber JM. Neoadjuvant treatment response and outcomes in locally advanced rectal cancer: Establishing oncologic benchmarks. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3545. PMID 28020305 DOI: 10.1200/Jco.2011.29.15_Suppl.3545 |
0.387 |
|
| 2011 |
Park IJ, Hu C, Rodriguez-Bigas MA, You YN, Skibber JM, Eng C, Wolff RA, Das P, Crane CH, Chang GJ. Oncologic and functional hazards of obesity among patients with locally advanced rectal cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 3553. PMID 28020291 DOI: 10.1200/Jco.2011.29.15_Suppl.3553 |
0.341 |
|
| 2011 |
Hu CY, Delclos GL, Chan W, Du XL. Post-treatment surveillance in a large cohort of patients with colon cancer. The American Journal of Managed Care. 17: 329-36. PMID 21718080 |
0.568 |
|
| 2011 |
Hu CY, Delclos GL, Chan W, Du XL. Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer. Medical Oncology (Northwood, London, England). 28: 1062-74. PMID 20714945 DOI: 10.1007/S12032-010-9644-7 |
0.607 |
|
| 2011 |
Hu C, Xing Y, Cormier J, Chang G. The Validity Of Cancer Specific Mortality Within The Surveillence, Epidemiology, And End Results Registry Journal of Surgical Research. 165: 270. DOI: 10.1016/J.Jss.2010.11.439 |
0.371 |
|
| 2010 |
Silberfein EJ, Kattepogu KM, Hu CY, Skibber JM, Rodriguez-Bigas MA, Feig B, Das P, Krishnan S, Crane C, Kopetz S, Eng C, Chang GJ. Long-term survival and recurrence outcomes following surgery for distal rectal cancer. Annals of Surgical Oncology. 17: 2863-9. PMID 20552409 DOI: 10.1245/s10434-010-1119-8 |
0.376 |
|
| 2009 |
Hu C, Xing Y, Cormier JN, Chang GJ. The validity of cause of death coding within the Surveillance, Epidemiology, and End Results (SEER) Registry. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6544. PMID 27964060 DOI: 10.1200/Jco.2009.27.15_Suppl.6544 |
0.42 |
|
| 2009 |
Overman MJ, Hu C, Wolff RA, Chang GJ. Impact of lymph node evaluation on survival for small bowel adenocaricnoma: Analysis of the Surveillance, Epidemiology and End Results (SEER) database. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 4596. PMID 27963112 DOI: 10.1200/Jco.2009.27.15_Suppl.4596 |
0.329 |
|
| 2009 |
Chang GJ, Hu CY, Eng C, Skibber JM, Rodriguez-Bigas MA. Practical application of a calculator for conditional survival in colon cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5938-43. PMID 19805670 DOI: 10.1200/JCO.2009.23.1860 |
0.306 |
|
| 2009 |
Xing Y, Chang GJ, Hu C, Askew RL, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Lucci A, Cormier JN. QS334. Conditional Survival Estimates Provide Better Prognostic Information for Melanoma Survivors: Results From the SEER Dataset 1988-2000 Journal of Surgical Research. 151: 297. DOI: 10.1016/J.Jss.2008.11.642 |
0.309 |
|
| 2008 |
Chang GJ, Hu C, Rodriguez-Bigas MA, Skibber JM. Improving colon cancer prognosis using Index of Metastasis: A SEER analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 4019. PMID 27949255 DOI: 10.1200/Jco.2008.26.15_Suppl.4019 |
0.467 |
|
| Show low-probability matches. |